Futura Medical plc
FAMDF
$0.15
$0.017.14%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 410.90% | 409.34% | 314.19% | 329.18% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 410.90% | 409.34% | 314.19% | 329.18% | -- |
| Cost of Revenue | 298.37% | 297.09% | 176.57% | 186.59% | -- |
| Gross Profit | 480.22% | 478.38% | 434.38% | 453.80% | -- |
| SG&A Expenses | -23.64% | -23.87% | 66.85% | 72.89% | 172.76% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.69% | 4.37% | 70.09% | 76.24% | 68.36% |
| Operating Income | 108.74% | 108.71% | 142.17% | 143.69% | -31.61% |
| Income Before Tax | 108.86% | 108.84% | 144.58% | 146.20% | -29.72% |
| Income Tax Expenses | 176.53% | 176.19% | 31.95% | 29.49% | 71.95% |
| Earnings from Continuing Operations | 106.32% | 106.30% | 157.39% | 159.47% | -50.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 106.32% | 106.30% | 157.39% | 159.47% | -50.22% |
| EBIT | 108.74% | 108.71% | 142.17% | 143.69% | -31.61% |
| EBITDA | 110.16% | 110.12% | 146.78% | 148.48% | -30.30% |
| EPS Basic | 106.12% | 106.00% | 155.26% | 156.76% | -44.12% |
| Normalized Basic EPS | 109.38% | 109.23% | 140.74% | 142.31% | -25.49% |
| EPS Diluted | 105.10% | 106.00% | 152.63% | 154.05% | -44.12% |
| Normalized Diluted EPS | 109.38% | 109.23% | 140.74% | 142.31% | -25.49% |
| Average Basic Shares Outstanding | 0.63% | 0.63% | 4.34% | 4.34% | 4.58% |
| Average Diluted Shares Outstanding | 1.08% | 1.08% | 9.85% | 9.85% | 4.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |